Ono Pharmaceutical Co., Ltd. (TYO:4528)

Ono Pharmaceutical Revenue

Ono Pharmaceutical had revenue of 116.34B JPY in the quarter ending September 30, 2026, a decrease of -10.23%. This brings the company's total for the last twelve months to 491.15B, down -2.48% year-over-year. In the fiscal year ending March 31, 2026, Ono Pharmaceutical had annual revenue of 515.79B with 5.94% growth. That makes Ono Pharmaceutical the 3,740th largest company in the world by revenue and 370th in Japan.

• Revenue (ttm): 491.15B
• Revenue Growth: -2.48%
• P/S Ratio: 2.34
• Revenue / Employee: 116.77M
• Employees: 4,206
• Market Cap: 1.15T

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Japan 287.09B 55.7%
• Americas 197.06B 38.2%
• Asia 17.72B 3.4%
• Europe 12.32B 2.4%
• Others 1.60B 0.3%

Fiscal year ended Mar 31, 2026 See the full Ono Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	515.79B	28.91B	5.94%
Mar 31, 2025	486.87B	-15.80B	-3.14%
Mar 31, 2024	502.67B	55.49B	12.41%
Mar 31, 2023	447.19B	85.83B	23.75%
Mar 31, 2022	361.36B	52.08B	16.84%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error